Imunon
在场
高管
查看带有其 10 名主要高管的组织结构图
Imunon 搜索最多的简介
- Michael Tardugno, Executive Chairman and Chief Executive Officer
- Christine Pellizzari, Director
- Frederick Fritz, Director
高管在Imunon变化
- Michael Tardugno 曾任 Executive Chairman of the Board, 现升职为 Executive Chairman and Chief Executive Officer (新闻发布的2024三月13号).
- Corinne Le Goff, President and Chief Executive Officer and Director, 已经离开公司 (新闻发布的2024三月13号).
- Sebastien Hazard已作为Chief Medical Officer加入公司 (新闻发布的2023十二月11号).
创建提醒
跟踪 Imunon 的高管变动
生物技术
Imunon 拥有 2,286 家竞争者，其中包括 Lonza (瑞士)、Eurofins (卢森堡) 和 Adaptive Phage Therapeutics (美国(美洲))。
Popular M&A news in 生物技术
- Karius 刚刚宣布为 100 筹款数百万美元。 (公布2024五月3号).
- Transcarent 刚刚宣布为 126 筹款数百万美元。 (公布2024五月2号).
- WindRose Health Investors has announced the acquisition of SubjectWell (公布2024五月2号).
生物技术 行业的其他推荐联系人
消息
Imunon 的最新新闻稿
- Press Releases | IMUNON INC.
- Press Releases – IMUNON
- RSS News Feeds | Celsion Corporation
- Celsion Corporation Issues Letter to Stockholders | Celsion Corporation
- Celsion Announces Common Stock Purchase Agreement with Lincoln Park Capital and Provides Updates on OVATION 2 Study | Celsion Corporation
- Celsion Corporation Restructures its Strategic Loan Facility | Celsion Corporation
- Press Releases | Celsion Corporation
- Celsion Corporation Reports Second Quarter 2020 Financial Results and Provides Business Update | Celsion Corporation
- Celsion Corporation to Hold Second Quarter 2020 Financial Results and Business Update Conference Call on Friday, August 14, 2020 | Celsion Corporation
- Celsion Corporation to Continue Following Patients in Phase III OPTIMA Study for Overall Survival | Celsion Corporation
- View more press releases Close
关于 Imunon 的社交媒体
保持联系
通过电子邮件联系联系该企业高管，包括 Michael Tardugno 
